Studying development of disease through temporally controlled gene expression in the salivary gland

Annals of the New York Academy of Sciences

Volumn 842, Issue , 1998, Pages 181-187

  Furth, Priscilla A ^a,b,c   Li, Minglin ^a,b,c   Hennighausen, Lothar ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c INSTITUTE OF HUMAN VIROLOGY   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS LARGE T ANTIGEN;

ANTIGEN EXPRESSION; CARCINOGENESIS; CELL TRANSFORMATION; CONFERENCE PAPER; FIBROSIS; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION REGULATION; HYPERPLASIA; NONHUMAN; ONCOGENE; PHENOTYPE; PROTEIN EXPRESSION; SALIVARY GLAND CANCER; SIMIAN VIRUS 40; SUBMANDIBULAR GLAND; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

EID: 0031959566     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09646.x     Document Type: Conference Paper

References (32)

1. FURTH, P.A. 1997. Conditional control of gene expression in the mammary gland. Mammary Gland Biol. Neoplasia. 2: 373-383.
2. FURTH, P.A., L. ST.ONGE, H. BOGER, P. GRUSS, M. GOSSEN, A. KISTNER, H. BUJARD & L. HENNINGHAUSEN. 1994. Temporal control of gene expression in transgenic mice by a tetracycline responsive promoter. Proc. Natl. Acad. Sci. USA 91: 9302-9306.
3. EWALD, D., M. LI, S. EFRAT, G. AUER, R.J. WALL, P.A. FURTH & L. HENNINGHAUSEN. 1996. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273: 1384-1386.
4. MAYFORD, M., M.E. BACH, Y.-Y. HUANG, L. WANG, R.D. HAWKINS & E.R. KANDEL. 1996. Controlling memory formation using regulated expression of a CaMKII transeene. Science 274: 1678-1683.
5. SCHULTZE, N., Y. BURKI, Y. LANG, U. CERTA & H. BLUETHMANN. 1996. Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nature Biotechnol. 14: 499-503.
6. KISTNER, A., M. GOSSEN, F. ZIMMERMAN, J. JERECIC, C. ULLMER, H. LUBBERT & H. BU-JARD. 1996. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93: 10933-10938.
7. FISHMAN, G.I., M.L. KAPLAN & P.M. BUTTRICK. 1994. Tetracycline-regulated cardiac gene expression in vivo. J. Clin. Invest. 93: 1864-1868.
8. YU, Z., C.S. REDFERN & G.I. FISHMAN. 1996. Conditional transgene expression in the heart. Circ. Res. 79: 691-697.
9. HENNINGHAUSEN, L., R. WALL, U. TILLMANN, M. LI & P.A. FURTH. 1995. Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system. J. Cell. Biochem. 59: 463-472.
10. GOSSEN, M. & H. BUJARD. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89: 5547-5551.
11. GOSSEN, M., S. FREUNDLIB, G. BENDER, G. MULLER, W. HILLEN & H. BUJARD. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769.
12. HINRICHS, W., C. KISKER, M. DUVEL, A. MULLER, K. TOVAR, W. HILLEN & W. SAENGER. 1994. Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance. Science 264: 418-420.
13. TZENG, Y.-J., E.GUHL, M. GRAESSMANN & A. GRAESSMANN. 1993. Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid gene. Oncogene 8: 1965-1971.
14. KUHLMANN, E., P.G. TERHUNE & D.S. LONGNECKER. 1993. Evaluation of c-K-ras in pancreatic carcinomas from Ela-1, SV40E transgenic mice. Carcinogenesis 14: 2649-2651.
15. INOUE, T., Y. HIRABAYASHI, H. MITSUI, Y. FURUTA, Y. SUDA, S. AIZAWA & Y. IKAWA. 1994. Experimental model for MDS-like myelodysplasia in transgenic mice harboring the SV40 large-T antigen under an immunoglobulin enhancer. Leukemia 8(Suppl. 1): S202-S205.
16. MAXWELL, P.H., M.K. OSMOND, C.W. PUGH, A. HERYET, L.G. NICHOLLS, C.C. TAN, B.G. DOE, D.J.P. FERGUSON, M.H. JOHNSON & P.J. RATCLIFFE. 1994. Erythropoietin-producing cells in transgenic mice expressing SV40 large T antigen directed by erythropoietin control sequences. Ann. N.Y. Acad. Sci. 718: 356-358.
17. TEITZ, T., T.S.B. YEN, J.C. CHANG & Y.W. KAN. 1994. SV40 T antigen directed by a powerful erythroid enhancer-promoter produced sarcomas and pancreatic tumors but not erythroid-specific tumors in transgenic mice. DNA Cell Biol. 13: 705-710.
18. SANDMÖLLER, A., R. HALTER, E. GÓMEZ-LA-HOZ, H.-J. GRÖNE, G. SUSKE, D. PAUL & M. BEATO. 1994. The uteroglobin promoter targets expression of the SV40 T antigen to a variety of secretory epithelial cells in transgenic mice. Oncogene 9: 2805-2815.
19. WILKIE, T.M., R.A. SCHMIDT, M. BAETSCHER & A. MESSING. 1994. Smooth muscle and bone neoplasms in transgenic mice expressing SV40 T antigen. Oncogene 9: 2889-2895.
20. SERVENIUS, B., J. VERNACHIO, J. PRICE, L.C. ANDERSSON & P.A. PETERSON. 1994. Metastasizing neuroblastomas in mice transgenic for simian virus 40 large T (SV40T) under the olfactory marker protein gene promoter. Cancer Res. 54: 5198-5205.
21. HINO, O., T. KITAGAWA, K. NOMURA, K. OHTAKE, L. CUI, Y. FURUTA & S. AIZAWA. 1991. Hepatocarcinoaenesis in transgenic mice carrying albumin-promoter SV40 T antigen gene. J. Cancer Res. 82: 1226-1233.
22. SCHIRMACHER, P., W.A. HELD, D. YONG, L. BIENPICA & C.E. ROGLER. 1991. Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large T antigen transgenic mice. Am. J. Pathol. 139: 231-241.
23. HELD, W.A., J. PAZIK, J.G. O'BRIEN, K. KERNS, M. GOBEY, R. MEIS, L. KENNY & Y. Rus-TUM. 1994. Genetic analysis of liver tumorigenesis in SV40 T antigen transgenic mice implies a role for imprinted genes. Cancer Res. 54: 6489-6495.
24. DRUCKER, D.J. 1994. Molecular pathophysiology of glucagon-SV40 T antigen transgenic mice. Am. J. Physiol. Endocrinol. Metab. 267: E629-E635.
25. CHEAH, K.S.E., A. LEVY, P.A. TRAINOR, A.W. WAI, T. KUFFNER, C.L. So, K.K.H. LEUNG, R.H. LOVELL-BADGE & P.P.L. TAM. 1995. Human COL2A1-directed SV40T antigen expression in transaenic and chimeric mice results in abnormal skeletal development. J. Cell Biol. 128: 223-237.
26. SYMONDS, H., L. KRALL, L. REMINGTON, M. SAENZ-ROBLES, S. LOWE, T. JACKS & T. VAN DYKE. 1994. p53-dependent apoptosis suppresses tumor growth and proaression in vivo. Cell 78: 703-711.
27. CHRISTOFORI, G., P. NAIK & D. HANAHAN. 1994. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Science 369: 414-417.
28. NAIK, P., J. KARRIM & D. HANAHAN. 1996. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes & Dev. 10: 2105-2116.
29. LI, M., J. HU, K. HEERMEIER, L. HENNIGHAUSEN & P.A. FURTH. 1996. Expression of a viral oncoprotein during development of the mammary gland alters cell fate and function: induction of p53 independent apoptosis is followed by impairment of milk protein production in surviving cells. Cell Growth & Differ 7: 3-11.
30. BAR-PELED, U., M. LI, M., R. JAEGER, L. HENNIGHAUSEN, H. WEIHER & P.A. FURTH. Unpublished observations.
31. ST.ONGE, L., P.A. FURTH & P. GRUSS. 1996. Temporal control of Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res. 24: 3875-3877.
32. EFRAT, S., D. FUSCO-DEMANE, H. LEMBERO, O. AL EMRAN & X. WANG. 1995. Targeting conditional expression of TAg to pancreatic acinar cells using the tetracycline responsive system in transgenic mice. Proc. Natl. Acad. Sci. USA 92: 3576-3580.